Boston Healthcare Associates (BHA) contributes market access and strategy positioning — globally and inclusive of complex and emerging markets – enabling early decisions with expertise in HEOR that optimizes commercialization strategies and improves market adoption.
Navigate a complex policy and payment environment to unlock value
Payers and health systems are seeking value, demanding more from novel drugs, devices, and diagnostic technologies than ever before. Stakeholders need to understand how new technologies and services deliver better outcomes and an improved patient experience while controlling costs.
Veranex has a deep understanding of the global payer landscape, including government and private payers. We also go beyond policy makers to understand financial risk at the hospital or health system level, to better align the value our clients deliver with the expectations of reimbursement and funding stakeholders.
Veranex’s global panel of payer and health technology assessment leadership, combined with a rigorous understanding of the clinical and economic burden of disease, allows us to build strategic reimbursement roadmaps that address everything from coding to policy, pricing, and evidence development. And with our implementation expertise, Veranex is with you every step of the way, delivering the tools that help you communicate and capture value.
Market Access Solutions
- Coding analysis and implementation
- Decision impact studies
- Evidence and market access roadmap
- Patient preference studies
- Pricing strategy
- Reimbursement assessment and strategy
- Value communication tools